Stock listing
P731 Stock Price, News, Filings & Events — Medexus Pharmaceuticals Inc.
Selected listing: P731 · FWB · EUR · DE
This page tracks Medexus Pharmaceuticals Inc.'s P731:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following P731:FWB. P731:FWB is the stock-level entry point for investors researching Medexus Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- P731:FWB
- Asset type
- Stock
- Market cap
- $112.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- FWB
- Currency
- EUR
Medexus Pharmaceuticals Inc. P731:FWB stock context
This page tracks Medexus Pharmaceuticals Inc.'s P731:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following P731:FWB. P731:FWB is the stock-level entry point for investors researching Medexus Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Medexus Pharmaceuticals Inc.
Medexus Announces Fiscal Q1 2027 Results With Strongest Quarter of Product-Level Performance of GRAFAPEX (Treosulfan) to Date
August 10, 2026
Medexus Schedules First Fiscal Quarter 2027 Conference Call
July 30, 2026
Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection
June 25, 2026
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call
June 16, 2026
Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada
June 9, 2026
Medexus Pharmaceuticals Inc. earnings calls
Medexus Pharmaceuticals Inc. (MDP) Q1 2027 Earnings Call
August 11, 2026 · Replay with transcript and chapters
Medexus Pharmaceuticals Inc. (MDP) Q4 2026 Earnings Call
June 26, 2026 · Replay with transcript and chapters
Medexus Pharmaceuticals Inc. (MDP) Q3 2026 Earnings Call
February 12, 2026 · Replay with transcript and chapters
Medexus Pharmaceuticals Inc. (MDP) Q2 2026 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Medexus Pharmaceuticals Inc. (MDP) Q1 2026 Earnings Call
August 13, 2025 · Replay with transcript and chapters
Medexus Pharmaceuticals Inc. (MDP) Q4 2025 Earnings Call
June 26, 2025 · Replay with transcript and chapters
Research Medexus Pharmaceuticals Inc.
Medexus Pharmaceuticals Inc. investor report
Review AI stock analysis and investor report context for P731:FWB.
Medexus Pharmaceuticals Inc. company profile
View the public company page for Medexus Pharmaceuticals Inc. on 6ix.
Medexus Pharmaceuticals Inc. news
Read company news and market updates connected to Medexus Pharmaceuticals Inc..
Medexus Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Medexus Pharmaceuticals Inc..
Alternate listings
MDP:TSX
CA · CAD
Alternate listing for Medexus Pharmaceuticals Inc.; the primary context on this page is P731:FWB.
MEDXF:OTC
US · USD
Alternate listing for Medexus Pharmaceuticals Inc.; the primary context on this page is P731:FWB.
MDP:NEO
CA · CAD
Alternate listing for Medexus Pharmaceuticals Inc.; the primary context on this page is P731:FWB.